カテゴリー： QYResearch, 世界

世界の組換えタンパク質薬市場

◆英語タイトル：Global Recombinant Protein Drugs Market Professional Survey Report 2019
◆商品コード：DATA909X14175
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：材料・化学
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、組換えタンパク質薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換えDNA、組換えRNAに、用途別には、製薬産業、その他にセグメント区分し、組換えタンパク質薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・組換えタンパク質薬の世界市場概要
・組換えタンパク質薬の製造コスト構成分析
・組換えタンパク質薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・組換えタンパク質薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・組換えタンパク質薬のセグメント分析（種類別）
（組換えDNA、組換えRNA）
・組換えタンパク質薬のセグメント分析（用途別）
（製薬産業、その他）
・組換えタンパク質薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novo Nordisk、Amgen、Sanofi、Eli Lilly、Merck Serono、Ortho Biotech、Roche、Kyowa Hakko Kirin、Pharmingen、Abcam、GenSci、SL PHARM、Dongbao Pharm、Ankebio、NCPC、Heng Rui、）
・組換えタンパク質薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Recombinant Protein Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Protein Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Protein Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Protein Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Protein Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Recombinant DNA
Recombinant RNA

Segment by Application
Pharmaceutical Industry
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Recombinant Protein Drugs
1.1 Definition of Recombinant Protein Drugs
1.2 Recombinant Protein Drugs Segment by Type
1.2.1 Global Recombinant Protein Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Recombinant DNA
1.2.3 Recombinant RNA
1.3 Recombinant Protein Drugs Segment by Applications
1.3.1 Global Recombinant Protein Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Pharmaceutical Industry
1.3.3 Other
1.4 Global Recombinant Protein Drugs Overall Market
1.4.1 Global Recombinant Protein Drugs Revenue (2014-2025)
1.4.2 Global Recombinant Protein Drugs Production (2014-2025)
1.4.3 North America Recombinant Protein Drugs Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Protein Drugs Status and Prospect (2014-2025)
1.4.5 China Recombinant Protein Drugs Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Protein Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Protein Drugs Status and Prospect (2014-2025)
1.4.8 India Recombinant Protein Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
2.3 Manufacturing Process Analysis of Recombinant Protein Drugs
2.4 Industry Chain Structure of Recombinant Protein Drugs

3 Development and Manufacturing Plants Analysis of Recombinant Protein Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Protein Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Protein Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Recombinant Protein Drugs Production and Capacity Analysis
4.2 Recombinant Protein Drugs Revenue Analysis
4.3 Recombinant Protein Drugs Price Analysis
4.4 Market Concentration Degree

5 Recombinant Protein Drugs Regional Market Analysis
5.1 Recombinant Protein Drugs Production by Regions
5.1.1 Global Recombinant Protein Drugs Production by Regions
5.1.2 Global Recombinant Protein Drugs Revenue by Regions
5.2 Recombinant Protein Drugs Consumption by Regions
5.3 North America Recombinant Protein Drugs Market Analysis
5.3.1 North America Recombinant Protein Drugs Production
5.3.2 North America Recombinant Protein Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Protein Drugs Import and Export
5.4 Europe Recombinant Protein Drugs Market Analysis
5.4.1 Europe Recombinant Protein Drugs Production
5.4.2 Europe Recombinant Protein Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Protein Drugs Import and Export
5.5 China Recombinant Protein Drugs Market Analysis
5.5.1 China Recombinant Protein Drugs Production
5.5.2 China Recombinant Protein Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Protein Drugs Import and Export
5.6 Japan Recombinant Protein Drugs Market Analysis
5.6.1 Japan Recombinant Protein Drugs Production
5.6.2 Japan Recombinant Protein Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Protein Drugs Import and Export
5.7 Southeast Asia Recombinant Protein Drugs Market Analysis
5.7.1 Southeast Asia Recombinant Protein Drugs Production
5.7.2 Southeast Asia Recombinant Protein Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Protein Drugs Import and Export
5.8 India Recombinant Protein Drugs Market Analysis
5.8.1 India Recombinant Protein Drugs Production
5.8.2 India Recombinant Protein Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Protein Drugs Import and Export

6 Recombinant Protein Drugs Segment Market Analysis (by Type)
6.1 Global Recombinant Protein Drugs Production by Type
6.2 Global Recombinant Protein Drugs Revenue by Type
6.3 Recombinant Protein Drugs Price by Type

7 Recombinant Protein Drugs Segment Market Analysis (by Application)
7.1 Global Recombinant Protein Drugs Consumption by Application
7.2 Global Recombinant Protein Drugs Consumption Market Share by Application (2014-2019)

8 Recombinant Protein Drugs Major Manufacturers Analysis
8.1 Novo Nordisk
8.1.1 Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served
8.1.2 Novo Nordisk Product Introduction, Application and Specification
8.1.3 Novo Nordisk Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Recombinant Protein Drugs Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi
8.3.1 Sanofi Recombinant Protein Drugs Production Sites and Area Served
8.3.2 Sanofi Product Introduction, Application and Specification
8.3.3 Sanofi Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eli Lilly
8.4.1 Eli Lilly Recombinant Protein Drugs Production Sites and Area Served
8.4.2 Eli Lilly Product Introduction, Application and Specification
8.4.3 Eli Lilly Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Merck Serono
8.5.1 Merck Serono Recombinant Protein Drugs Production Sites and Area Served
8.5.2 Merck Serono Product Introduction, Application and Specification
8.5.3 Merck Serono Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Ortho Biotech
8.6.1 Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served
8.6.2 Ortho Biotech Product Introduction, Application and Specification
8.6.3 Ortho Biotech Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Roche
8.7.1 Roche Recombinant Protein Drugs Production Sites and Area Served
8.7.2 Roche Product Introduction, Application and Specification
8.7.3 Roche Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kyowa Hakko Kirin
8.8.1 Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served
8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
8.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pharmingen
8.9.1 Pharmingen Recombinant Protein Drugs Production Sites and Area Served
8.9.2 Pharmingen Product Introduction, Application and Specification
8.9.3 Pharmingen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Abcam
8.10.1 Abcam Recombinant Protein Drugs Production Sites and Area Served
8.10.2 Abcam Product Introduction, Application and Specification
8.10.3 Abcam Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 GenSci
8.12 SL PHARM
8.13 Dongbao Pharm
8.14 Ankebio
8.15 NCPC
8.16 Heng Rui

9 Development Trend of Analysis of Recombinant Protein Drugs Market
9.1 Global Recombinant Protein Drugs Market Trend Analysis
9.1.1 Global Recombinant Protein Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Protein Drugs Regional Market Trend
9.2.1 North America Recombinant Protein Drugs Forecast 2019-2025
9.2.2 Europe Recombinant Protein Drugs Forecast 2019-2025
9.2.3 China Recombinant Protein Drugs Forecast 2019-2025
9.2.4 Japan Recombinant Protein Drugs Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Protein Drugs Forecast 2019-2025
9.2.6 India Recombinant Protein Drugs Forecast 2019-2025
9.3 Recombinant Protein Drugs Market Trend (Product Type)
9.4 Recombinant Protein Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Protein Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Recombinant Protein Drugs
Table Global Recombinant Protein Drugs Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Protein Drugs Production Market Share by Types in 2018
Figure Recombinant DNA Product Picture
Figure Recombinant RNA Product Picture
Table Global Recombinant Protein Drugs Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Recombinant Protein Drugs Consumption Market Share by Applications in 2018
Figure Pharmaceutical Industry
Figure Other
Figure Global Recombinant Protein Drugs Revenue (Million USD) (2014-2025)
Figure Global Recombinant Protein Drugs Production (K Doses) (2014-2025)
Figure North America Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Figure China Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Figure India Recombinant Protein Drugs Market Size (Million USD) (2014-2025)
Table Recombinant Protein Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2018
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Industry Chain Structure of Recombinant Protein Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Protein Drugs Manufacturing Plants Distribution
Table Recombinant Protein Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Protein Drugs Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Recombinant Protein Drugs Production (K Doses) of Major Manufacturers (2014-2019)
Table Recombinant Protein Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Protein Drugs Production Share by Manufacturers in 2018
Table Recombinant Protein Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Protein Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Protein Drugs Revenue Share by Manufacturers in 2018
Table Recombinant Protein Drugs Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Protein Drugs Production by Regions 2014-2019 (K Doses)
Table Global Recombinant Protein Drugs Production Market Share by Regions 2014-2019
Figure Global Recombinant Protein Drugs Production Market Share by Regions in 2018
Table Global Recombinant Protein Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Protein Drugs Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Protein Drugs Revenue Market Share by Regions in 2018
Table Global Recombinant Protein Drugs Consumption by Regions 2014-2019 (K Doses)
Table Global Recombinant Protein Drugs Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure North America Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure Europe Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure Europe Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure China Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure China Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure Japan Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure Japan Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure India Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses)
Figure India Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Protein Drugs Production, Consumption Import and Export (K Doses)
Figure Global Consumption Recombinant Protein Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Protein Drugs Market Share by Application (2014-2019)
Table Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served
Table Novo Nordisk Recombinant Protein Drugs Product Introduction, Application and Specification
Table Novo Nordisk Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Novo Nordisk Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Novo Nordisk Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Novo Nordisk Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Novo Nordisk Recombinant Protein Drugs Main Business and Markets Served
Table Amgen Recombinant Protein Drugs Production Sites and Area Served
Table Amgen Recombinant Protein Drugs Product Introduction, Application and Specification
Table Amgen Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Amgen Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Amgen Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Amgen Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Amgen Recombinant Protein Drugs Main Business and Markets Served
Table Sanofi Recombinant Protein Drugs Production Sites and Area Served
Table Sanofi Recombinant Protein Drugs Product Introduction, Application and Specification
Table Sanofi Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Sanofi Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Sanofi Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Sanofi Recombinant Protein Drugs Main Business and Markets Served
Table Eli Lilly Recombinant Protein Drugs Production Sites and Area Served
Table Eli Lilly Recombinant Protein Drugs Product Introduction, Application and Specification
Table Eli Lilly Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Eli Lilly Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Eli Lilly Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Eli Lilly Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Eli Lilly Recombinant Protein Drugs Main Business and Markets Served
Table Merck Serono Recombinant Protein Drugs Production Sites and Area Served
Table Merck Serono Recombinant Protein Drugs Product Introduction, Application and Specification
Table Merck Serono Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Serono Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Merck Serono Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Merck Serono Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Merck Serono Recombinant Protein Drugs Main Business and Markets Served
Table Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served
Table Ortho Biotech Recombinant Protein Drugs Product Introduction, Application and Specification
Table Ortho Biotech Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Ortho Biotech Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Ortho Biotech Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Ortho Biotech Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Ortho Biotech Recombinant Protein Drugs Main Business and Markets Served
Table Roche Recombinant Protein Drugs Production Sites and Area Served
Table Roche Recombinant Protein Drugs Product Introduction, Application and Specification
Table Roche Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Roche Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Roche Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Roche Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Roche Recombinant Protein Drugs Main Business and Markets Served
Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served
Table Kyowa Hakko Kirin Recombinant Protein Drugs Product Introduction, Application and Specification
Table Kyowa Hakko Kirin Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Main Business and Markets Served
Table Pharmingen Recombinant Protein Drugs Production Sites and Area Served
Table Pharmingen Recombinant Protein Drugs Product Introduction, Application and Specification
Table Pharmingen Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Pharmingen Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Pharmingen Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Pharmingen Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Pharmingen Recombinant Protein Drugs Main Business and Markets Served
Table Abcam Recombinant Protein Drugs Production Sites and Area Served
Table Abcam Recombinant Protein Drugs Product Introduction, Application and Specification
Table Abcam Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Abcam Recombinant Protein Drugs Production Growth Rate (2014-2019)
Table Abcam Recombinant Protein Drugs Production Market Share (2014-2019)
Figure Abcam Recombinant Protein Drugs Revenue Market Share (2014-2019)
Table Abcam Recombinant Protein Drugs Main Business and Markets Served
Table GenSci Recombinant Protein Drugs Production Sites and Area Served
Table SL PHARM Recombinant Protein Drugs Production Sites and Area Served
Table Dongbao Pharm Recombinant Protein Drugs Production Sites and Area Served
Table Ankebio Recombinant Protein Drugs Production Sites and Area Served
Table NCPC Recombinant Protein Drugs Production Sites and Area Served
Table Heng Rui Recombinant Protein Drugs Production Sites and Area Served
Figure Global Recombinant Protein Drugs Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Recombinant Protein Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Protein Drugs Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Recombinant Protein Drugs by Type (2019-2025)
Table Global Consumption (K Doses) of Recombinant Protein Drugs by Application (2019-2025)
Table Recombinant Protein Drugs Distributors List
Table Recombinant Protein Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Novo Nordisk、Amgen、Sanofi、Eli Lilly、Merck Serono、Ortho Biotech、Roche、Kyowa Hakko Kirin、Pharmingen、Abcam、GenSci、SL PHARM、Dongbao Pharm、Ankebio、NCPC、Heng Rui、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の組換えタンパク質薬市場(Global Recombinant Protein Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp